Platelet glycoprotein IIb-IIIa receptor (GPIIb-IIIa) antagonists derived from amidinoindoles.

被引:9
|
作者
Sall, DJ [1 ]
Arfsten, AE [1 ]
Berry, DR [1 ]
Denney, ML [1 ]
Harms, CS [1 ]
McCowan, JR [1 ]
Ray, JK [1 ]
Scarborough, RM [1 ]
Um, SL [1 ]
Utterback, BG [1 ]
Jakubowski, JA [1 ]
机构
[1] COR THERAPEUT INC, S SAN FRANCISCO, CA 94080 USA
关键词
D O I
10.1016/0960-894X(95)00563-9
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of substituted amidinoindoles have been prepared as mimics of the RGD sequence and were studied as antagonists of the platelet glycoprotein IIb-IIIa receptor (GPIIb-IIIa). The agents were potent and selective antagonists of GPIIb-IIIa. Compared to their acyclic counterparts, the amidinoindole series bound with 10- to 20-fold greater affinity, indicating the advantages of added conformational restriction and/or hydrophobicity in the basic region of RGD mimics.
引用
收藏
页码:81 / 86
页数:6
相关论文
共 50 条
  • [31] Participation of IIb-IIIa glycoprotein in spontaneous platelet aggregation
    Sirotkina, O. V.
    Zabotina, A. M.
    Taraskina, A. E.
    Sivachenko, E. B.
    Zueva, E. E.
    Kadinskaya, M. I.
    Buryachkovskaya, L. I.
    Uchitel', I. A.
    Khaspekova, S. G.
    Vavilova, T. V.
    Shvartsman, A. L.
    Mazurov, A. V.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 143 (04) : 422 - 425
  • [32] Surgical implications of platelet glycoprotein IIb-IIIa inhibition
    Dyke, C
    Gammie, JS
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (06): : 1083 - 1084
  • [33] Participation of IIb-IIIa glycoprotein in spontaneous platelet aggregation
    O. V. Sirotkina
    A. M. Zabotina
    A. E. Taraskina
    E. B. Sivachenko
    E. E. Zueva
    M. I. Kadinskaya
    L. I. Buryachkovskaya
    I. A. Uchitel’
    S. G. Khaspekova
    T. V. Vavilova
    A. L. Shvartsman
    A. V. Mazurov
    [J]. Bulletin of Experimental Biology and Medicine, 2007, 143 : 422 - 425
  • [34] Synthesis and pharmacology of orally active, isoxazoline glycoprotein IIb-IIIa receptor antagonists
    Xue, CB
    Wityak, J
    Sielecki, TM
    Cain, GA
    Liu, J
    Bostrom, LL
    DiMeo, SV
    Higley, CA
    Lalka, GK
    Tobin, AE
    Frietze, WE
    Emmett, G
    Mousa, SA
    Sze, JY
    Thoolen, MJ
    Reilly, TM
    DeGrado, WF
    Olson, RE
    Wexler, RR
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 132 - MEDI
  • [35] Design, synthesis and pharmacology of novel isoxazoline glycoprotein IIb-IIIa receptor antagonists
    Wityak, J
    Pinto, DJ
    Wang, SG
    Sze, JY
    Mousa, SA
    Olson, RE
    Wexler, RR
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 131 - MEDI
  • [36] MONOCLONAL-ANTIBODIES TO PLATELET GLYCOPROTEIN IB (GPIB) OR GLYCOPROTEIN IIB-IIIA (GPIIB-IIIA) INHIBIT ADHESION OF PLATELETS TO PURIFIED SOLID-PHASE VONWILLEBRAND-FACTOR (VWF)
    DANTON, MC
    ZALESKI, A
    OLSON, JD
    [J]. FEDERATION PROCEEDINGS, 1987, 46 (03) : 423 - 423
  • [37] EFFECT OF ZINC ON THE INTERACTION BETWEEN FIBRINOGEN AND PLATELET GLYCOPROTEIN IIB/IIIA (GPIIB/IIIA)
    TRYBULEC, M
    COOK, JJ
    NIEWIAROWSKI, S
    [J]. THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1067 - 1067
  • [38] Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists
    Dickfeld, T
    Ruf, A
    Pogatsa-Murray, G
    Müller, I
    Engelmann, B
    Taubitz, W
    Fischer, J
    Meier, O
    Gawaz, M
    [J]. THROMBOSIS RESEARCH, 2001, 101 (02) : 53 - 64
  • [39] Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future
    Giuseppe De Luca
    Stefano Savonitto
    Arnoud W. J. van’t Hof
    Harry Suryapranata
    [J]. Drugs, 2015, 75 : 1229 - 1253
  • [40] Platelet Glycoprotein IIb/IIIa Receptor Antagonists And Their Use In Elderly Patients
    Koon-Hou Mak
    Mark B. Effron
    David J. Moliterno
    [J]. Drugs & Aging, 2000, 16 : 179 - 187